Assessment of the serial changes of vessel wall contents in atherosclerotic coronary lesion with bioresorbable everolimus-eluting vascular scaffolds using Shin's method: an IVUS study by Shin, E.S. (Eun-Seok) et al.
ORIGINAL PAPER
Assessment of the serial changes of vessel wall contents
in atherosclerotic coronary lesion with bioresorbable
everolimus-eluting vascular scaffolds using Shin’s method:
an IVUS study
Eun-Seok Shin • Hector M. Garcia-Garcia • Scot Garg •
Jurgen Ligthart • Leif Thuesen • Dariusz Dudek •
John A. Ormiston • Patrick W. Serruys
Received: 8 July 2010 / Accepted: 21 October 2010
 Springer Science+Business Media, B.V. 2010
Abstract Although serial changes in necrotic core
and calcium are regarded as surrogates for the biore-
sorption process in patients treated with the bioresorb-
able everolimus-eluting vascular scaffolds (BVS),
these temporal changes have not yet been fully
investigated. Shin’s method may be offer a more
suitable technique for this analysis because it includes
all the contents of both the lumen and vessel wall. The
purpose of this study was to assess the serial changes of
necrotic core and dense calcium content in coronary
lesions that were treated with a BVS implant using
Virtual Histology intravascular ultrasound (VH-IVUS)
analyzed using Shin’s method. A total of 29 patients (92
coronary segments) were imaged to evaluate the serial
changes in necrotic core and dense calcium using
Shin’s method. Lesions treated with a BVS implant
were analyzed with serial VH-IVUS assessments, i.e.,
pre- and post-stenting, and at 6 months and 2 years
follow-up. In Shin’s method contours are drawn around
the IVUS catheter (instead of delineating the lumen)
and the vessel. The mean necrotic core area decreased
by 6.9% from post-stenting to 6 months (1.71 ±
1.03 mm2 vs. 1.36 ± 0.91 mm2, P = 0.027), and by
20.5% (1.71 ± 1.03 mm2 vs. 1.20 ± 0.70 mm2,
P = 0.003) from post-steting to 2 years; while the
mean dense calcium areas decreased by 27.2%
(1.07 ± 0.55 mm2 vs. 0.78 ± 0.64 mm2, P = 0.039)
from post-stenting and 2 years. At 2 years, absolute
necrotic core and dense calcium content were signif-
icantly decreased as compared to post-stenting values.
The present study demonstrates that the bioresorption
process in patients who undergoing BVS device
implantation can be assessed using VH-IVUS analysed
using Shin’s method.
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Introduction
Bioresorbable scaffolds have the potential to reduce
adverse events such as stent thrombosis (ST) when
compared to conventional metallic stents, because
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drug elution and vessel scaffolding are only provided
by the implant until the vessel has healed, and as such
no longer triggers for ST, such as non-endothelialized
stent struts, or drug polymers are present during long
time [1]. In several studies, of patients undergoing
implantation of the bioresorbable everolimus-eluting
vascular scaffolds (BVS: Abbott Vascular, Santa
Clara, CA), necrotic core and dense calcium assessed
using Virtual Histology intravascular ultrasound
(VH-IVUS) have been used as surrogates to monitor
the bioresorption process. This came about following
the observed abrupt increase in necrotic core and
dense calcium seen immediately after BVS implan-
tation, and the gradually diminished levels seen with
follow-up. In these previous reports, the bioresorption
process has been explored using conventional VH-
IVUS analysis [1, 2]. The accuracy of this conven-
tional analysis however, may have been affected
because some BVS strut information may have been
missed due to the presence of a medial grey stripe
(which is arbitrary delineated in the color frames of
VH-IVUS and represents the location of the media
layer of the vessel wall), and also because of temporal
changes in the appearance of the BVS strut which
might have precluded proper contouring. These
pertinent issues can be overcome by analysing the
VH-IVUS using Shin’s method, which includes all
the content of the lumen and vessel wall, and has a
high reproducibility [3], thereby allowing complete
characterization of serial changes in composition
within the external elastic membrane and the
catheter.
The purpose of this study was to assess whether
serial changes in ‘‘necrotic core’’ and ‘‘dense cal-
cium’’ content assessed using VH-IVUS (these are
artefacts since VH-IVUS has not been validated for
this use, therefore we will write them between
quotation marks) and analysed using a new method
(Shin’s method).
Methods
Study patients
The study design for the ABSORB Cohort A trial has
been published elsewhere [4]. VH-IVUS images were
obtained from 29 out the 30 patients participating in
the ABSORB Cohort A trial who treated with the
BVS implant; one patient was excluded because no
follow-up images were available. The study protocol
was approved by the institutional ethics committee,
and written informed consent was obtained from all
patients.
VH-IVUS acquisition and examination
In brief, IVUS data were acquired with commercially
available phased-array IVUS catheters (Eagle Eye
Gold 2.9-F 20 MHz, Volcano Corporation, Rancho
Cordova, USA) by a dedicated VH-IVUS console
(Volcano Therapeutics, Rancho Cordova, USA). Four
major components (fibrous: green; fibrofatty: light-
green; dense calcium: white; and necrotic core: red)
were characterized and image acquisition was ECG-
gated. After intracoronary injection of 200 lg nitro-
glycerine, continuous pullback of the IVUS catheter
was performed using a motorized pullback device at
0.5 mm/s. Data of both pullbacks were stored on hard
disk for off-line analysis. VH-IVUS analysis was
performed by one experienced IVUS analyst (E.S.S.)
in an independent core laboratory (Cardialysis BV,
Rotterdam, The Netherlands) using pcVH 2.2 off-line
software.
Procedures
In Shin’s method, instead of measuring the lumen as
previously described in the conventional method of
VH-IVUS analysis, contours around the IVUS cath-
eter are drawn without following the leading edge of
the interface lumen intima. According to Shin’s
method, when there is a ‘‘flare’’ (ring-down artifact)
around the IVUS catheter, this catheter contour must
be drawn away from this flare. The catheter contour
was manually detected. In addition, to avoid coverage
of scaffold struts by the superimposed medial stripe,
the vessel contour was drawn purposefully slightly
outwards from the struts but without including the
adventitia (Fig. 1).
On each cross section, polymeric scaffold struts
were detected as areas of apparent ‘‘dense calcium’’
surrounded by ‘‘necrotic core’’. We used the change
in quantitative analysis of these areas between
implantation and follow-up as a surrogate assessment
of the bioresorption process. In addition, we analyzed
the relative amount of ‘‘necrotic core and dense
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calcium’’ with vessel volume to compare serial
changes in the percentage for ‘‘necrotic core and
dense calcium’’.
Experimental study
In a harvested pig coronary artery flushed continu-
ously with saline solution at 37C, a VH-IVUS
pullback was performed prior to any intervention.
ECG gating was simulated using an external source.
Next, a BVS device (3.0 9 18 mm) was implanted at
nominal pressure and immediately a second VH-
IVUS pullback was performed.
The aim for this experimental study was to
compare the change of ‘‘necrotic core and dense
calcium’’ after stenting measured by Shin’s method
between harvested pig coronary artery and Absorb
trial, Cohort A with the delta value of ‘‘necrotic core
and dense calcium’’ before and after BVS implanta-
tion by Cohort A.
Statistical analysis
Analyses were performed with SPSS 16.0 (SPSS Inc.,
Chicago, Illinois). Discrete variables are presented as
counts and percentages. Continuous variables are
presented as means ± 1SD. Serial changes of
‘‘necrotic core and dense calcium’’ were compared
using paired Student’s t test. Nonparametric analysis
with Wilcoxon signed rank test was also done. A two-
sided P value of less than 0.05 indicated statistical
significance.
Results
Patient characteristics are shown in Table 1. The
mean patient age was 62 years, and 18 participants
were male. The study vessels were the left anterior
descending artery in 15, the left circumflex artery in 9
and the right coronary artery in 7 cases.
Fig. 1 To avoid coverage of stent struts by the superimposed
medial stripe, the vessel contour was drawn purposefully
slightly outwards from the struts but without including the
adventitia. Shin’s method shows some ‘‘necrotic core and
dense calcium’’ for the bioabsorbable everolimus-eluting stent
in the grey medial stripe (c and e) that was not shown with the
conventional method (a and d; two white arrow heads) (DC
dense calcium, NC necrotic core)
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Serial change of ‘‘necrotic core and dense
calcium’’
Table 2 shows serial changes in ‘‘necrotic core’’,
‘‘dense calcium’’ and the mean vessel area and
volume (external elastic membrane), After stenting,
‘‘necrotic core and dense calcium’’ content increased
because BVS struts were characterized as ‘‘dense
calcium’’ with large quantities of ‘‘necrotic core’’
surrounding them. Overall, after stenting there was a
gradual reduction during follow-up in mean vessel
area, ‘‘necrotic core’’ area and ‘‘dense calcium’’ area
(mean vessel area: 14.1 ± 3.5, 13.9 ± 3.4,
12.8 ± 3.6 mm2, mean ‘‘necrotic core’’ area:
1.71 ± 1.03, 1.36 ± 0.91, 1.20 ± 0.70 mm2, mean
‘‘dense calcium’’ area: 1.07 ± 0.55, 0.85 ± 0.54,
0.78 ± 0.64 mm2 at post-stenting, 6 months and
2 years follow-up, respectively). From post-stenting
to 6 months, the mean ‘‘necrotic core’’ area decreased
significantly (-6.9 ± 55.6%, P = 0.027). From post-
stenting to 2 years, mean ‘‘necrotic core and
dense calcium’’ areas decreased also significantly
(-20.5 ± 33.6%, P = 0.003 and -27.2 ± 48.8%,
P = 0.039, respectively) (Fig. 2). In volumetric
analysis, from post-stenting to 2 years, ‘‘necrotic
core’’ volume decreased significantly (-16.4 ±
42.1%, P = 0.023) whilst a trend was seen for a
reduction in ‘‘dense calcium’’ (-22.0 ± 58.1%,
P = 0.057).
Experimental results
In the harvested pig coronary artery, there was an
immediate increase in ‘‘necrotic core and dense
calcium’’ areas after BVS deployment, which is
comparable to the increase observed following BVS
implantation in the ABSORB cohort A study
(Table 3).
Table 1 Baseline characteristics
N = 30
Age, years 62 ± 9
Male 18 (60)
Diabetes 1 (3)
Hypertension 18 (60)
Current smoker 6 (20)
Hypercholesterolemia 19 (63)
Study vessel
LAD 15 (47)
LCX 9 (30)
RCA 7 (23)
Lesion length, mm 12.83 ± 3.74
Values are presented as number (%) or mean ± SD, LAD left
anterior descending artery, LCX left circumflex artery, RCA
right coronary artery
Table 2 Serial changes of mean area and volume of vessel (EEM), ‘‘necrotic core and dense calcium’’ in pre- and post-stenting, and
at 6 months and 2 years follow-up
Mean area (mm2) Volume (mm3)
EEM NC DC EEM NC DC
Pre-stenting (n = 14) 13.2 ± 3.5 0.87 ± 0.73 0.39 ± 0.40 180.6 ± 64.2 12.1 ± 11.0 5.4 ± 5.9
Post-stenting (n = 28) 14.1 ± 3.5 1.71 ± 1.03 1.07 ± 0.55 173.1 ± 60.6 21.5 ± 13.7 13.3 ± 7.5
6 months (n = 28) 13.9 ± 3.4 1.36 ± 0.91 0.85 ± 0.54 192.0 ± 98.0 19.4 ± 16.4 11.6 ± 7.5
2 years (n = 22) 12.8 ± 3.6 1.20 ± 0.70 0.78 ± 0.64 163.3 ± 72.6 15.5 ± 10.5 10.2 ± 8.4
Relative 4(%) post-stenting
vs. 6 months
-1.5 ± 8.8 -6.9 ± 55.6 -5.9 ± 63.1 6.5 ± 32.0 -3.1 ± 53.7 -1.9 ± 60.8
Relative 4(%) 6 months
vs. 2 years
-4.6 ± 7.8 -7.7 ± 49.9 -7.7 ± 70.6 -0.3 ± 39.3 -1.8 ± 62.3 -4.3 ± 74.1
Relative 4(%) post-stenting
vs. 2 years
-6.7 ± 13.4 -20.5 ± 33.6 -27.2 ± 48.8 -3.3 ± 30.3 -16.4 ± 42.1 -22.0 ± 58.1
P value post-stenting vs. 6 months 0.268 0.027 0.081 0.240 0.338 0.198
P value 6 months vs. 2 years 0.065 0.162 0.363 0.432 0.250 0.404
P value post-stenting vs. 2 years 0.058 0.003 0.039 0.327 0.023 0.057
Values are presented as mean ± SD, EEM external elastic membrane, NC necrotic core, DC dense calcium, 4 difference
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Discussion
The main finding of this study is that the mean area of
‘‘necrotic core and dense calcium’’ as assessed using
Shin’s method decreased significantly between base-
line and 2-years follow-up in the lesion of BVS
implantation. The serial changes in absolute volumes
of ‘‘necrotic core and dense calcium’’ seen on VH-
IVUS analyzed using Shin’s method, can be used as a
surrogate marker of the bioresorption process in
coronary lesions treated with the BVS implant.
Biodegradable stents offers several distinct advan-
tages over conventional bare or drug coated metallic
stents. These include potential reductions in adverse
events such as ST, and a reduced requirement for
long-term dual anti-platelet therapy as foreign mate-
rials could be decreased at long-term. Physiologically,
the absence of a rigid metallic casing can facilitate the
return of vessel vasomotion, adaptive shear stress, late
luminal enlargement and late expansive remodeling.
Additional long-term advantages include an improve-
ment in future treatment options, as percutaneous
coronary intervention or surgical revascularization
can be performed in areas of previous stenting without
restriction. Furthermore, biodegradable stents can
negate some of the other problems associated with
use of permanent metallic stents such as the covering
of side branches, overhang at ostial lesions, and the
‘blooming effect’ seen when using non-invasive
imaging techniques such as CT angiography or
MRI [5].
Biodegradable stents are currently undergoing
clinical trials, and currently the BVS implant which
represents the most extensively studied device,
remains the most important source of knowledge
regarding the bioresorption process in vivo. In the
ABSORB study implanted BVS polymeric struts
appeared as highly echogenic/calcific structures on
VH-IVUS (Fig. 1). After device implantation an
increase in ‘‘dense calcium’’ with surrounding
‘‘necrotic core’’ was observed. This has been attrib-
uted to the polymeric struts, and therefore ‘‘dense
calcium’’ with surrounding ‘‘necrotic core’’ has been
suggested as the VH fingerprint of polymeric struts
[2]. This hypothesis is supported by the results of our
experimental study in which the recorded increase in
‘‘necrotic core’’ area and ‘‘dense calcium’’ area was
similar to that observed in Absorb cohort A.
Although several previous papers with the same
patient cohort reported a decrease in the relative
amounts of ‘‘necrotic core and dense calcium’’, the
Fig. 2 Serial changes in mean areas of ‘‘necrotic core and dense calcium’’ (display error bars = 95% Confidence intervals)
Table 3 Absolute differences in ‘‘necrotic core and dense
calcium’’ areas following BVS implantation in pig and human
coronary arteries
Absolute difference between
pre- and post-stenting
BVS in harvested pig
coronary artery (N = 1)
Absorb cohort
A (N = 12)
Stent area (mm2) 2.43 ± 0.49 2.49 ± 0.78
NC area (mm2) 1.37 ± 0.25 1.60 ± 0.64
DC area (mm2) 1.06 ± 0.28 0.90 ± 0.39
% NC to vessel area 8.9 ± 1.6 8.7 ± 2.6
% DC to vessel area 6.9 ± 1.9 5.1 ± 2.1
Values are presented as mean ± SD, NC necrotic core, DC
dense calcium, Stent area = post-stenting NC and DC areas
minus pre-stenting NC and DC areas
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absolute amount of ‘‘necrotic core and dense cal-
cium’’ failed to show statistically significant decrease
[2] except for ‘‘necrotic core’’ area at 2 years [1]. In
the present study, at 2 years, mean area of ‘‘necrotic
core’’ shrank by 20.5%, whilst mean area of ‘‘dense
calcium’’ decreased by 27.2% (1.07 ± 0.55 mm2 at
post-stenting vs. 0.78 ± 0.64 mm2 at 2 years).
In a recent study, we introduced a new catheter
contour based method of measuring necrotic core and
dense calcium (Shin’s method), in contrast to the
conventional lumen contour based one. We have
previously demonstrated that Shin’s method has a
good correlation with conventional methods for the
calculation of necrotic core and dense calcium, with
shorter measuring times and excellent reproducibility
in both stented and non-stented lesions [3]. In
longitudinal studies, accurate assessment must take
into account the variability in: IVUS catheters,
analyst and method of analysis. For example, in a
previous study the inter-catheter variability was 6-8%
for necrotic core and dense calcium when analyzed
by the same observer [6]. In a similar assessment
using Shin’s method the relative differences in
necrotic core and dense calcium were only 1% in
intra-observer comparisons (Shin et al., submitted).
Therefore Shin’s method can be used in order to
minimize the impact of the other factors that
contribute to variability in longitudinal assessments.
Although the bioresorption process has been
previously explored using VH-IVUS in human cor-
onary arteries [2], some BVS strut information may
have been missed because of the presence of the
medial grey stripe (Fig. 1), and/or because of tem-
poral changes in the BVS strut appearance which
might have precluded proper contouring (i.e., struts in
the vicinity of a calcified area are hard to discriminate
from calcium). Shin’s method draws a catheter
contour (instead of a lumen contour), thereby
including all contents of the lumen and vessel wall,
thus allowing a complete analysis of serial changes in
plaque composition, (i.e., necrotic core and dense
calcium) which can be used as a surrogate of the
bioresorption process (Fig. 3). Therefore Shin’s
method achieves a more complete characterization
of all components within the vessel.
Limitations
This study had several limitations. (1) The sample
size is small and therefore, serial changes in ‘‘necrotic
core and dense calcium’’ content should be inter-
preted cautiously. (2) VH-IVUS has not been
Fig. 3 Serial assessment using Shin’s method by Virtual
Histology intravascular ultrasound. Pre-stenting, there is a large
plaque. After stenting, the lumen has enlarged and stent struts
are depicted as ‘‘necrotic core with dense calcium’’. At
6 months, the stent struts remained visible with partial reduction
of the luminal area. At 2 years, the endoluminal ‘‘dense
calcium’’ depicting struts has decreased, which is consistent
with strut absorption. (NC necrotic core, DC dense calcium)
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specifically validated for the assessment of polymeric
struts in vitro and ex vivo. In addition, the ‘‘necrotic
core and dense calcium’’ seen after the implantation
of BVS device are artefacts and not real tissue types,
since virtual histology has never been validated for
this use. (3) It is difficult to assess, if not impossible,
whether plaque contents have progressed or regressed
after complete resorption of stent strut at follow-up in
this study. For instance, if the plaque progressed at
2 year follow-up, there is a possibility for ‘‘necrotic
core with dense calcium’’ to be bigger, in contrast, if
the plaque regressed at 2 year follow-up, there is a
possibility for ‘‘necrotic core with dense calcium’’ to
be smaller.
Conclusions
At 2 years, absolute ‘‘necrotic core and dense
calcium’’ content were significantly decreased as
compared to post-stenting values. The present study
demonstrates that the bioresorption process in
patients who undergoing BVS device implantation
can be assessed using VH-IVUS analysed using
Shin’s method.
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